Health systems across the country are making it easier for primary care clinicians to order genetic tests for patients who ...

AI-driven genomics startups leverage technology to analyze genetic data, predict predispositions, and offer personalized ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

Rates of genetic testing for autism and intellectual and development disorders were associated with race, gender, and insurance company.

Significant racial disparities persisted in genetic testing for inborn errors of immunity despite the removal of financial ...

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...

In honor of Rare Disease Day on February 28, 2025, Morgan Lewis is publishing a series of posts on As Prescribed and Health ...

He clicked open a dashboard created by Nucleus Genomics, a Founders Fund-backed startup that gets saliva samples sequenced and then compares the DNA results to extensive data linking health issues ...

Thainakarin Hospital has announced its readiness to provide services at the Thainakarin Precision Oncology Center (TPOC), one ...